SEPRAPACK



Trademark Coverage

No Class Specified

Bioresorbable material for use as a sinus stent in nasal surgery

Owner

Genzyme Corporation

Business in CAMBRIDGE, MA

Owns 417 trademarks

Timeline
  • Nov 29
    2013
    Cancelled SEC 8 (10 Yr)/Expired Section 9
  • May 24
    2008
    Registered SEC 8 (6 Yr) Accepted & SEC 15 ACK
  • May 12
    2008
    Assigned To Paralegal
  • Apr 25
    2008
    TEAS Section 8 & 15 Received
  • Dec 27
    2007
    Case File In TICRS
  • May 21
    2004
    TEAS Change Of Correspondence Received
  • Apr 22
    2003
    Registered Principal Register
  • Feb 19
    2003
    Allowed Principal Register SOU Accepted
  • Feb 13
    2003
    Assigned To Examiner
  • Feb 10
    2003
    Statement Of Use Processing Complete
  • Dec 16
    2002
    Use Amendment Filed
  • Dec 16
    2002
    TEAS Statement Of Use Received
  • Oct 01
    2002
    NOA Mailed SOU Required From Applicant
  • Jul 09
    2002
    Published For Opposition
  • Jun 19
    2002
    Notice Of Publication
  • Feb 25
    2002
    Approved For PUB Principal Register
  • Feb 25
    2002
    Assigned To Examiner
  • Feb 10
    2002
    Assigned To Examiner
  • Dec 24
    2001
    Correspondence Received In Law Office
  • Jun 27
    2001
    Final Refusal Mailed
  • Mar 02
    2001
    Correspondence Received In Law Office
  • Sep 07
    2000
    Non Final Action Mailed
  • Sep 07
    2000
    Assigned To Examiner